News

DXC Technology and Accelya Join Forces for Airline Innovations

DXC Technology and Accelya Join Forces for Airline Innovations

DXC Technology and Accelya Team Up to Innovate Airline Services

In a significant development for the airline industry, DXC Technology (NYSE: DXC) has announced a partnership with Accelya to enhance airport retail experiences and streamline system integrations for airlines around the globe. The collaboration aims to bring forth modern solutions that are crucial for the evolution of airline operations, further ensuring that travelers have a seamless and enriched experience.

Enhancing Offer and Order Management

Accelya is known for its cutting-edge Offer, Order, Settle technology, which is further empowered by DXC's extensive expertise in industry solutions. The partnership combines Accelya's innovative technological solutions with DXC's leadership in the field, allowing airlines to embrace modernization effectively. This collaboration facilitates the deployment of a comprehensive, cloud-based retailing platform known as FLX ONE (OOSD), tailored to meet the rapidly changing demands of airline travelers.

Streamlining System Integrations

With DXC's extensive experience in systems integration, the partnership will enable airlines to manage their technology infrastructure more efficiently. This means that airlines not only get to modernize their operations but can also innovate their service offerings, ensuring that customer experiences are at the forefront of their objectives.

FLX ONE: A Comprehensive Retailing Platform

The FLX ONE retailing platform currently processes over 30 billion offers worldwide daily, aiding airlines in managing seat bookings and flight inventory effectively. This robust solution provides an opportunity for airlines to utilize a single overarching platform that encompasses all stages of The International Air Transport Association (IATA) Offers, Orders, Settle & Delivery. This results in a more personalized and frictionless journey for travelers from booking to boarding.

Operational Efficiency and Cost Reduction

Accelya’s implementation of DXC's proprietary Departure Control Systems (DCS) is set to enhance operational efficiencies and elevate passenger experiences right at the airport. Furthermore, the FLX ONE platform will help reduce overhead costs for airlines, allowing them to create and deliver more tailored offers and improved customer service functionalities throughout the travel experience.

Commitment to Innovation

"FLX ONE is a future-focused platform that empowers airlines with total control over their retailing processes," shares Sam Gilliland, CEO of Accelya. He emphasizes the importance of adding FLX Delivery through DXC's airport technology, turning FLX ONE into a comprehensive solution that competes effectively with legacy systems.

DXC and Accelya are also positioning DXC as Accelya's preferred systems integrator. This strategic alignment leverages DXC's robust industry knowledge and its proven capability to execute large-scale system integrations, which is critical for advancing innovation across the airline sector.

Advanced Technologies to Elevate Customer Experiences

Chris Drumgoole, Managing Director of DXC's Global Infrastructure Services, underscores the power of transformational technologies within business operations. He notes that the collaboration with Accelya is expected to deliver vital value to airlines focused on modernization while enhancing customer experiences and maximizing return on investment.

About Accelya

Accelya is a premier global software provider, serving over 200 airlines with its open, modular software platforms that facilitate growth and customer satisfaction. With a robust infrastructure backed by AWS, Accelya processes approximately 350,000 offers per second and handles transactions worth around $100 billion annually. The company leads more than 50% of global New Distribution Capability (NDC) transactions, showcasing its operational scalability and reliability.

Empowering Airlines for Future Success

With 40 years of experience in the industry and a workforce of 2,500 spread across ten international offices, Accelya stands at the forefront of innovation-led growth for airlines. The partnership with DXC Technology is poised to provide airlines with the tools they need to regain control over their operations and navigate the future of airline retailing successfully.

Frequently Asked Questions

What is the purpose of the partnership between DXC Technology and Accelya?

The partnership aims to enhance airport retail experiences and accelerate system integrations for airlines globally.

What does the FLX ONE platform offer airlines?

FLX ONE provides a cloud-based platform that helps airlines manage offers, orders, and ticketing efficiently, reducing costs and improving customer experiences.

How does DXC Technology support Accelya?

DXC Technology provides its expertise in systems integration, operational efficiency, and airport technology to support Accelya's offerings.

What are the benefits of using the FLX ONE retailing platform?

FLX ONE enables airlines to manage ticketing, inventory, and reservations on a unified platform, enhancing personalization and overall efficiency.

How does Accelya's technology impact the airline industry?

Accelya's solutions drive innovation, simplify airline operations, and improve the customer journey from booking to boarding.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 295

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 282

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 143

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 86

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Oral Semaglutide Curbs Heavy Drinking: CU Study Insights

Updated Category News Views 12

New Frontiers in Tackling Alcohol Use Disorder Diabetes meds aren't just boxing in sugar levels; they're taking swings at alcohol cravings, too. The University of Colorado Anschutz threw their hat in the ring with a study that put oral semaglutide—usually in the diabetes and weight loss circuit—to a different test. Turns out, it's packing a punch against heavy...

Continue Reading
Julie Van Kleeck Strengthens Leadership at Paragon Space

Updated Category News Views 121

Julie Van Kleeck Joins Paragon Space Development Corporation Board Paragon Space Development Corporation (Paragon) proudly announces the appointment of Julie Van Kleeck to its Board of Directors. With a remarkable background in the space technology sector, Julie is set to enhance Paragon's mission with her extensive market insights and solid operational experience. Rich...

Continue Reading
Exploring Advanced Techniques for Fracture Healing in Orthopaedics

Updated Category News Views 302

Micromotion Nailing for Enhanced Fracture Healing OrthoXel is thrilled to announce an important presentation by Dr. Hannah Dailey, Co-Founder and Chief Scientific Officer, focusing on the innovative technique of micromotion nailing aimed at accelerating fracture healing. This presentation will be highlighted at an esteemed meeting gathering leading experts in the field of...

Continue Reading
Resilient Job Market Gains Amid Signs of Slowing Growth Ahead

Updated Category News Views 191

Overview of Recent Labor Market Trends The US economy has shown unexpected strength, adding more jobs than anticipated recently, instilling fresh optimism regarding the labor market's near-term stability. With political changes on the horizon, the economy's performance under the new administration remains a topic of interest. Nonetheless, we can assert that the incoming...

Continue Reading
MD Hyperbaric Expands Presence in Key U.S. Markets

Updated Category News Views 6

Expanding the Oxygen Therapy Frontier When you're talking about healing that's both ancient and cutting-edge, hyperbaric oxygen therapy (HBOT) kind of steals the show. MD Hyperbaric, calling the shots since 2021, is breaking new ground in San Antonio, Las Vegas, and Rochester. Why This Matters HBOT isn't just another fancy healthcare fad. We're seeing a real push toward...

Continue Reading